Secures order worth USD 20-25 million from Turkey
Remedium Lifecare has entered into a strategic agreement with Angel Partners, UK, effective 29 July 2024, to acquire technology for manufacturing lithium carbonate in India.
The company has also signed an annual Supply Agreement with Alfa Chemicals and Solvents, Turkey, effective the same date.
Supplies of technical-grade lithium carbonate will commence in the January-March 2025 quarter.
The supplies for CY 2025 are valued at USD 20-25 million.
Technical-grade lithium carbonate is used in lithium-ion batteries for electric vehicles and portable electronics.
Also Read
Remedium has partnered with various contract manufacturers to produce technical-grade lithium carbonate using the technology from Angel Partners.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app